New research looking at the differences in tumour blood flow between patients of different sexes has been published by Acredit’s Dr Kine Mari Bakke and colleagues from the Acredit network across Norway.
In this new paper, Kine shows that the baseline flow of blood through a tumour may be a predictor of overall performance for patients with rectal cancers. Additionally, women appear to have a higher flow of blood through their tumours, which appears to have a significant impact on the overall survival experienced by these patients. Kine’s work may indicate that blood flow through the tumour should be included as one of the diagnostic surveys undertaken when a patient is initially diagnosed as the blood flow through the tumour may be important to the overall efficacy of any chemotherapy undertaken.
You can read this exciting new paper here.